Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Nadolsky notes, a higher 7.2 mg dose may be released in the future
She reports losing about 14 kilograms and hopes sharing her story will help others facing similar struggles
More specifically, the FDA label states that these medications may lead to thyroid C-cell tumors
If you are experiencing persistent vomiting, avoid drinking liquids during meals
Clinical trials vs real-world results What the clinical trials show The landmark SURMOUNT-5 trial published in 2025 compared these medications directly at standard maximum doses: 1 Mounjaro (tirzepatide 15 mg) produced 20.2% average weight loss Wegovy (semaglutide 2.4 mg) produced 13.7% average weight loss The 6.5 percentage point difference was statistically significant This trial used the maximum approved doses at the time (Mounjaro 15 mg, Wegovy 2.4 mg) and lasted 72 weeks
US$ 20.88
US$ 29.94
US$ 20.47
US$ 29.51
